Overview

An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy

Status:
Completed

Trial end date:
2013-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate clinical effectiveness and safety of golimumab with methotrexate (MTX) in the treatment of rheumatoid arthritis (RA) when compared to MTX alone.

Phase:

Phase 3

Details

Lead Sponsor:

Centocor, Inc.

Collaborator:

Schering-Plough

Treatments:

Antibodies, Monoclonal
Golimumab
Methotrexate